Abstract:West syndrome or infantile spasms is one of the most frequent epileptic syndromes in the first year of life. The clinical symptoms of infantile spasms are very different than any other type of seizure because of both the absence of paroxysmal motor phenomena (i.e., as in a convulsion) and the lack of significant duration of loss of consciousness (i.e., as in absence epilepsy). Infantile spasms may lead to misdiagnosis by pediatricians and other primary care providers. We assessed the missed diagnoses prior to … Show more
“…Riikonen [4,5] reported that patients of WS with a favorable outcome had normal neurodevelopment before the onset of the spasms. Nearly all previous studies on this variable reported similar results [3,7,10,[21][22][23][24][25][26]. The presence of parental consanguinity and epilepsy in near relatives showed no significant effect on prognosis in this study.…”
Section: Neuro-developmental and Social Outcomessupporting
confidence: 83%
“…Approximately 50% of patients with seizure onset before 12 months of age, excluding the neonatal period, suffer from WS characterized by infantile spasm (IS), psychomotor arrest or retardation, and hypsarrhythmia on electroencephalograms (EEG) [2][3][4]. Epileptic spasms most often show a temporal relationship with hypsarrhythmia, which is the typical interictal EEG activity in WS.…”
In this study, 37 (33.9%) patients had severe consequences as a result of WS. The majority of the rest could cope with daily life with varying degrees of assistance. Eight percent of the patients had a normal development. These results draw attention to the two-thirds of patients with WS who have the chance of an acceptable quality of life (QoL) with early diagnosis and therapeutic measures.
“…Riikonen [4,5] reported that patients of WS with a favorable outcome had normal neurodevelopment before the onset of the spasms. Nearly all previous studies on this variable reported similar results [3,7,10,[21][22][23][24][25][26]. The presence of parental consanguinity and epilepsy in near relatives showed no significant effect on prognosis in this study.…”
Section: Neuro-developmental and Social Outcomessupporting
confidence: 83%
“…Approximately 50% of patients with seizure onset before 12 months of age, excluding the neonatal period, suffer from WS characterized by infantile spasm (IS), psychomotor arrest or retardation, and hypsarrhythmia on electroencephalograms (EEG) [2][3][4]. Epileptic spasms most often show a temporal relationship with hypsarrhythmia, which is the typical interictal EEG activity in WS.…”
In this study, 37 (33.9%) patients had severe consequences as a result of WS. The majority of the rest could cope with daily life with varying degrees of assistance. Eight percent of the patients had a normal development. These results draw attention to the two-thirds of patients with WS who have the chance of an acceptable quality of life (QoL) with early diagnosis and therapeutic measures.
“…Так, S. Auvin и соавт. [9] сообщают о том, что пра-вильный диагноз не ставился примерно 80% детей (301 из 362 детей). В отечественной практике за-держка начала адекватной (в данном случае гормо-нальной) терапии, как правило, составляет несколь-ко месяцев.…”
“…Onset of spasms is often associated with developmental arrest or regression. The primary goal of treatment is to stop the spasms early in the course of the disease in order to minimize the developmental delay . Up to 20% of patients fail to respond to current standard of care (SoC) with hormonal therapy, vigabatrin, or their combination …”
Objective
Infantile spasm syndrome (ISS) is an epileptic encephalopathy without established treatment after the failure to standard of care based on steroids and vigabatrin. Converging lines of evidence indicating a role of NR2B subunits of the N‐methyl‐D‐aspartate (NMDA) receptor on the onset of spams in ISS patients, prompted us to test radiprodil, a negative allosteric NR2B modulator in preclinical seizure models and in infants with ISS.
Methods
Radiprodil has been tested in three models, including pentylenetetrazole‐induced seizures in rats across different postnatal (PN) ages. Three infants with ISS have been included in a phase 1b escalating repeated dose study.
Results
Radiprodil showed the largest protective seizure effects in juvenile rats (maximum at PN12, corresponding to late infancy in humans). Three infants resistant to a combination of vigabatrin and prednisolone received individually titrated doses of radiprodil for up to 34 days. Radiprodil was safe and well tolerated in all three infants, and showed the expected pharmacokinetic profile. One infant became spasm‐free and two showed clinical improvement without reaching spasm‐freedom. After radiprodil withdrawal, the one infant continued to be spasm‐free, while the two others experienced seizure worsening requiring the use of the ketogenic diet and other antiepileptic drugs.
Interpretation
Radiprodil showed prominent anti‐seizure effect in juvenile animals, consistent with the prevalent expression of NR2B subunit of the NMDA receptor at this age in both rodents and humans. The clinical testing, although preliminary, showed that radiprodil is associated with a good safety and pharmacokinetic profile, and with the potential to control epileptic spasms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.